	Increased Risk of Psoriasis in Young Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Cohort Study. Ann Dermatol Lee HJ, Chung J, Han K, Kim M. PMID: 42845208 [PubMed]
	Clinic-Based Proportion of Psoriatic Arthritis and HLA-B27 Distribution in Korean Psoriasis Patients: A Retrospective Study. Ann Dermatol Jung YW, Hwang S, Kim TG. PMID: 42845206 [PubMed]
	Long-Term Safety and Efficacy of Upadacitinib in Patients with Psoriatic Arthritis: 5-Year Results from the PhaseÂ 3 SELECT-PsAÂ 1 Study. Rheumatol Ther McInnes IB, Kato K, Magrey M, Merola JF, Kishimoto M, Haaland D, Coates LC, Lagunes I, Liu Y, Mancl E, Parikh B, Philips C. PMID: 42844553 [PubMed - as supplied by publisher]
	Secondary Publications From Biologic or Small-molecule Trials in Psoriasis: A Methodological Systematic Review. Br J Dermatol Tran HGN, Afach S, Guelimi R, Sbidian E, Le Cleach L. PMID: 42844238 [PubMed - as supplied by publisher]
	Associations Between Psoriasis and Endocrine Diagnoses in a Tertiary-Center Electronic Health Record Database: A Cross-Sectional Study. Clin Cosmet Investig Dermatol Sivadas A, Taylor D. PMID: 42841067 [PubMed]
	Efficacy and Safety of Icotrokinra (an Interleukin-23 Inhibitor) in the Management of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis. JMA J Siddiqi ZA, Rubab S, Alashkar FJ, Iqbal A, Mahdi NAA, Haque M, Khairati RA, Ayantoyinbo T, Qasim K, Shahzaib MA, Khan AJ, Masharifa F, Rehman MSU, Habib F. PMID: 42840331 [PubMed]
	Postmarketing reporting patterns of Candida-related events associated with bimekizumab and selective IL-17A inhibitors in psoriasis: a FAERS and JADER pharmacovigilance study. Front Pharmacol Zhong H, Liu Y, Yu Y, Yu Y, Hou G. PMID: 42840172 [PubMed]
	Gut Microbiota in Psoriasis: Evidence for Dysbiosis, Pathological Mechanisms, Causality, and Therapeutic Implications. Clin Cosmet Investig Dermatol Zhao N, Cao W, Liu W, Wu L, Huang R. PMID: 42836164 [PubMed]
	Integrative Network Toxicology Identifies NFKB1 and KIF11 as Candidate Genes Associated with 2-Hydroxyphenanthrene in the Context of Psoriasis. Clin Cosmet Investig Dermatol Shi H, Guo Y, Yuan H, Wang L, Zhang Y, Li Y. PMID: 42836112 [PubMed]
	Subclinical intestinal inflammation in psoriasis: a cross-sectional comparative study using fecal calprotectin. Cutan Ocul Toxicol Marsak M, Sener S, Güner ME, Turkmen D, Altunisik N, Kanat Z, Duman Y. PMID: 42832771 [PubMed - as supplied by publisher]
	Efficacy and safety of probiotic supplementation in psoriatic arthritis - a randomized controlled trial. Rheumatology (Oxford) Bosch P, Lackner A, Dreo B, Fessler J, Moazedi-Fürst F, Husic R, Séneca J, Haidmayer A, Stadlbauer V, Muralikrishnan AS, Thiel J, Stradner M. PMID: 42832303 [PubMed - as supplied by publisher]
	Zinc Status and Disease Severity in Psoriasis, Atopic Dermatitis, and Seborrheic Dermatitis: A Systematic Review and Metaâ€‘analysis. Nutr Rev Novita MG, Iswanty M, Wahab S, Djawad K, Bukhari A. PMID: 42832221 [PubMed - as supplied by publisher]
	Response to correspondence on 'Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS Study' by Luan et al. Ann Rheum Dis Torgutalp M, Poddubnyy D. PMID: 42829232 [PubMed - in process]
	Comments on "Real-world effectiveness and safety of apremilast in psoriatic arthritis: results from the multicenter Italian MAPSI II study". Clin Rheumatol Ariani A, Parisi S, Paroli M, Becciolini A. PMID: 42828583 [PubMed - as supplied by publisher]
	Effect of Biologic Therapy on Depression and Anxiety Symptoms in Patients With Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis. Br J Dermatol Tang J, Wen Y, Chen K, Sun M, Luo M, Shen M, Li Y, Wang C, Xiao Y, Chen X, Shen M. PMID: 42828417 [PubMed - as supplied by publisher]
	Short-course vunakizumab associated with rapid improvement of acute flares in paediatric generalised pustular psoriasis: a three-patient case series. Front Immunol Huang J, Li Y, Peng Y, Xia P, Hu F, Chen J. PMID: 42827962 [PubMed - indexed for MEDLINE]
	Multidimensional efficacy characterization of xeligekimab in moderate-to-severe plaque psoriasis: regional responses, treatment targets, and patient-reported outcomes from a randomized controlled trial. Front Immunol Huang K, Zhao Y, Yang C, Zhang J. PMID: 42827493 [PubMed - indexed for MEDLINE]
	INDIVIDUAL ARTICLE: Tildrakizumab for Real-World Psoriasis Care: Clinical Lessons From Medically Complex and Underserved Patient Populations. J Drugs Dermatol Cortes JA, Elewski B, Awan S, O'Donoghue M, Glazer A, Schlesinger T, Chovatiya R, Bunick CG, Kircik LH, Armstrong AW. PMID: 42826156 [PubMed - indexed for MEDLINE]
	Efficacy of Apremilast in Patients with Psoriasis with Limited Skin Involvement, Including High-Impact Site Involvement: A Pooled Analysis of Six Trials. Dermatol Ther (Heidelb) Strober B, Lebwohl M, van de Kerkhof P, Gold LS, Merola JF, Okubo Y, Gisondi P, Zhou Z, Chaudhari S, Deignan C, Mrowietz U. PMID: 42825996 [PubMed - as supplied by publisher]
	Generalized Pustular Psoriasis: A Cost-of-Illness and Health-Related Quality of Life Study in Italy. Pharmacoecon Open Borsoi L, Armeni P, Scopinaro AM, Gisondi P, Costa F. PMID: 42825981 [PubMed - as supplied by publisher]

Articles 1 - 20 / 28607

Page 1 of 1431



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy